
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is poised for continued growth due to their strong position in the contact lens market, as well as their expansive portfolio in the reproductive and women's care segments. The company's recent strategic review and potential sale of CooperSurgical could result in increased share repurchases, leading to higher EPS growth. However, risks include competition, consumer weakness, and currency fluctuations. Pricing decisions for new products like MiSight may also play a role in the company's ability to sustain growth. With its current growth trajectory and potential for future strategic moves, Cooper Companies is a promising investment opportunity.
Bears say
Cooper Companies is facing challenges in both its CooperVision and CooperSurgical segments with declining market growth, slowing sales, and unfavorable comparisons. The company's operating margin, while higher than expected, is still under pressure due to tariffs and increased competition. Additionally, despite the launch of its new product MyDay MiSight, the company's decision to eliminate trial lens fitting sets may hinder potential patient conversion and revenue growth in the long-term. These factors contribute to the negative outlook for the company's stock.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares